Wiaczeslaw Smolokowski, 10% Owner at Acrivon Therapeutics, Inc. (ACRV), sold 16 shares at $12.93 ($207) on 2023-06-26, disclosed to the SEC on 2023-06-28.
Open-market sale of $207 ACRV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KPTI | SELL | 2014-11-12 | $7.0M | — | Filing → |
| KPTI | SELL | 2014-09-30 | $8.5M | — | Filing → |